Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

November 30, 2008

Conditions
Head and Neck Cancer
Interventions
DRUG

docetaxel

RADIATION

radiation therapy

Trial Locations (9)

464-8681

Aichi Cancer Center, Nagoya

036-8562

Hirosaki University, School of Medicine, Hirosaki

260-8677

Chiba University, Chiba

236-0004

Yokohama City University, Yokohama

390-8621

Shinshu University Health Center, Matsumoto

634-8522

Nara Medical University Cancer Center, Nara

903-0215

Graduate School of Medical Science at the University of Ryukyu, Okinawa

431-31

Hamamatsu University School of Medicine, Hamamatsu

737-0023

National Hospital Organization - Medical Center of Kure, Hiroshima

All Listed Sponsors
lead

Aichi Cancer Center

OTHER

NCT00243113 - Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx | Biotech Hunter | Biotech Hunter